Growth Metrics

Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2020 - 2025)

Gilead Sciences' Non-Current Deferred Tax Liability history spans 10 years, with the latest figure at $402.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 44.48% year-over-year to $402.0 million; the TTM value through Dec 2025 reached $402.0 million, down 44.48%, while the annual FY2025 figure was $402.0 million, 44.48% down from the prior year.
  • Non-Current Deferred Tax Liability reached $402.0 million in Q4 2025 per GILD's latest filing, down from $597.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.1 billion in Q4 2022 to a low of $402.0 million in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.4 billion, with a median of $2.0 billion recorded in 2023.
  • Peak YoY movement for Non-Current Deferred Tax Liability: soared 40.54% in 2022, then plummeted 74.06% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $4.4 billion in 2021, then surged by 40.54% to $6.1 billion in 2022, then tumbled by 74.06% to $1.6 billion in 2023, then plummeted by 54.41% to $724.0 million in 2024, then plummeted by 44.48% to $402.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Non-Current Deferred Tax Liability are $402.0 million (Q4 2025), $597.0 million (Q3 2025), and $652.0 million (Q2 2025).